• 
• 
• 

FDA News and Drug Updates

FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer

FDA News

Ivosidenib Now FDA-Approved as First-Line Treatment for AML with IDH1 Mutation

FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma

Adverse Effects

Understanding Immunotherapy Late Adverse Effects in Cancer Survivors

Meg Barbor, MPH

Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer

Adverse Events Associated with Checkpoint Inhibitors

Alice Goodman

Managing Radiation-Related Side Effects in Patients with Human Papillomavirus–Associated Oral Cancer

Alice Goodman

Reasons for Emergency Department Visits Related to Immune Checkpoint Inhibitor Treatment

Phoebe Starr

View All Adverse Effects Articles

Immunotherapy

CAR T-Cell Therapy Fills Unmet Needs in Leukemia and Lymphoma

Wayne Kuznar

Genomic Markers of Response Improve Patient Selection for Immune Checkpoint Inhibitor Therapy

Wayne Kuznar

CAR T-Cell Therapy Associated with Unique, Acute Adverse Events Requiring Vigilant Monitoring

Wayne Kuznar

Adding Immunotherapy to Chemotherapy Extends Survival in Metastatic Triple-Negative Breast Cancer

Phoebe Starr

Avelumab plus Axitinib Combination Improves Outcomes in Advanced Renal-Cell Carcinoma

Wayne Kuznar

View All Immunotherapy Articles

Conference Correspondent

Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?

The Importance of Compassion: Perspective From a Lifelong Patient

Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer

Addressing the Second Victim Phenomenon

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

Oral Multiple Myeloma Medication Linked to Decreased Productivity Loss

View All Conference Correspondent Articles

Most Popular Articles

April 16, 2019 – FDA Approvals, News & Updates

Web Exclusives - FDA Approvals, News & Updates, In the News

FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

Web Exclusives - FDA Approvals, News & Updates, In the News, Lung Cancer

FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma

Web Exclusives - FDA Approvals, News & Updates, In the News

Navigating Hematologic Malignancies

Peg Rummel, RN, MHA, OCN, NE-BC

Best Practices in Patient Navigation – Navigating Hematologic Malignancies

FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer

Web Exclusives - Breast Cancer, FDA Approvals, News & Updates, In the News